<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02546141</url>
  </required_header>
  <id_info>
    <org_study_id>NL53912.081.15</org_study_id>
    <secondary_id>METC nr 15/18</secondary_id>
    <nct_id>NCT02546141</nct_id>
  </id_info>
  <brief_title>Postprandial Plasma Amino Acid Concentrations After Dairy Consumption</brief_title>
  <acronym>PARROT</acronym>
  <official_title>Postprandial Plasma Amino Acid Concentrations After Dairy Consumption</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NIZO Food Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>FrieslandCampina</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NIZO Food Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to obtain information about the change in postprandial amino acids in&#xD;
      blood over time, after consumption of different dairy products, in an elderly population and&#xD;
      how this relates to gastric emptying rate and feelings of satiety.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>iAUC for postprandial individual plasma amino acids</measure>
    <time_frame>0-300 min after consumption</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cmax for postprandial individual plasma amino acids</measure>
    <time_frame>0-300 min after consumption</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Tmax for postprandial individual plasma amino acids</measure>
    <time_frame>0-300 min after consumption</time_frame>
  </primary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Protein Digestion Kinetics</condition>
  <arm_group>
    <arm_group_label>skimmed milk (UHT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>skimmed milk (pasteurized)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>skimmed yoghurt</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>full-fat milk (UHT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-homogenized full-fat milk (pasteurized)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>full-fat cheese (semi-matured)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>whey protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>micellar casein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portion size that contains 25 g of protein, oral, single administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>skimmed milk (UHT)</intervention_name>
    <arm_group_label>skimmed milk (UHT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>skimmed milk (pasteurized)</intervention_name>
    <arm_group_label>skimmed milk (pasteurized)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>skimmed yoghurt</intervention_name>
    <arm_group_label>skimmed yoghurt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>full-fat milk (UHT)</intervention_name>
    <arm_group_label>full-fat milk (UHT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non-homogenized full-fat milk (pasteurized)</intervention_name>
    <arm_group_label>non-homogenized full-fat milk (pasteurized)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>full-fat cheese (semi-matured)</intervention_name>
    <arm_group_label>full-fat cheese (semi-matured)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>whey protein</intervention_name>
    <arm_group_label>whey protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>micellar casein</intervention_name>
    <arm_group_label>micellar casein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age over 60y&#xD;
&#xD;
          -  BMI 21-30 kg/m2&#xD;
&#xD;
          -  Non-smoking&#xD;
&#xD;
          -  Healthy as assessed by the NIZO lifestyle and health questionnaire&#xD;
&#xD;
          -  Regular and normal Dutch eating habits as assessed by the NIZO lifestyle and health&#xD;
             questionnaire (3 main meals per day)&#xD;
&#xD;
          -  Veins suitable for cannulation (blood sampling)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participation in any clinical trial including blood sampling and/or administration of&#xD;
             substances up to 30 days before Day 01 of this study&#xD;
&#xD;
          -  Having a history of medical or surgical events that may significantly affect the study&#xD;
             outcome, including: Inflammatory bowel disease, hepatitis, pancreatitis, ulcers,&#xD;
             gastrointestinal or rectal bleeding; major gastrointestinal tract surgery such as&#xD;
             gastrectomy, gastroenterostomy, or bowel resection; known or suspected&#xD;
             gastrointestinal disorders, colon or GI tract cancer&#xD;
&#xD;
          -  Use of the following medication: glucose lowering drugs, insulin; medication that may&#xD;
             impact gastric emptying (e.g. gastric acid inhibitors or laxatives)&#xD;
&#xD;
          -  Diagnosed with diabetes, being treated for high blood glucose or increased fasting&#xD;
             blood glucose (&gt; 7 mmol/l in finger prick blood) as assessed during screening visit&#xD;
&#xD;
          -  For men: Hb &lt;8,5 mmol/l as assessed during screening visit; for women: Hb &lt;7,5 mmol/l.&#xD;
&#xD;
          -  Use of protein supplements&#xD;
&#xD;
          -  Mental status that is incompatible with the proper conduct of the study&#xD;
&#xD;
          -  A self-reported reported food allergy or sensitivity to dairy ingredients&#xD;
&#xD;
          -  A self-reported allergy or sensitivity to acetaminophen&#xD;
&#xD;
          -  Alcohol consumption &gt; 28 units/week and 4/day&#xD;
&#xD;
          -  Reported unexplained weight loss or weight gain of &gt; 3 kg in the month prior to&#xD;
             pre-study screening, or intention to lose weight during the study period&#xD;
&#xD;
          -  Reported slimming or medically prescribed diet&#xD;
&#xD;
          -  Recent blood donation (&lt;1 month prior to Day 01 of the study)&#xD;
&#xD;
          -  Not willing or afraid to give up blood donation during the study&#xD;
&#xD;
          -  Personnel of NIZO food research or Wageningen University, department of Human&#xD;
             Nutrition, their partner and their first and second degree relatives&#xD;
&#xD;
          -  Not having a general practitioner&#xD;
&#xD;
          -  Not willing to accept information-transfer concerning participation in the study, or&#xD;
             information regarding his health, like laboratory results and eventual adverse events&#xD;
             to and from his general practitioner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>NIZO food research</name>
      <address>
        <city>Ede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <study_first_submitted>September 8, 2015</study_first_submitted>
  <study_first_submitted_qc>September 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2015</study_first_posted>
  <last_update_submitted>January 11, 2016</last_update_submitted>
  <last_update_submitted_qc>January 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

